Clinical Trial

Strengthening Inspiratory and Oropharyngeal Muscles in Moderate Obstructive Sleep Apnea Hypopnea Syndrome

Study acronym: REMI SAHOS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 29, 2025 (before its estimated August 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The Obstructive Sleep Apnea hypopnea Syndrome (OSAS), whose prevalence is 4% of the French population, can lead to serious health consequences (risk of road accidents, onset of cardiovascular disease, etc.). OSAS corresponds to a certain number of interruptions (apneas) or reductions (hypopneas) of ventilation during sleep. The weakening of the tone of the inspiratory and oropharyngeal muscles is one of the main causes of upper airways obstruction during the inspiratory phase.
Protocol Amendment History 6 amendments
This ClinicalTrials.gov record has been amended 6 times since 2024-06-18; most recent amendment 2025-01-28.
Status change: Not Yet Recruiting → Recruiting 2025-01-28
Trial Details
NCT Number NCT06471751
Lead Sponsor Centre Hospitalier Universitaire de Saint Etienne
Collaborators: Association aide à la recherche médicale de proximité (AIRE), Conseil national de l'ordre des masseurs-kinésithérapeutes
Conditions Obstructive Sleep Apnea
Enrollment 38 participants
Start Date 2024-12-30
Primary Completion 2026-08-01 (estimated)
Study Completion 2026-08-01 (estimated)
Updated on ClinicalTrials.gov 2025-01-29